IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOMahamaya Lifesciences

About Mahamaya Lifesciences

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity.The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs.The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.

Checklist Quality Analysis

Revenue Growth

Live IPOs

National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
Open  Close17th Sep 2026 - 21st Sep 2026
Issue Size22561.57 Cr
Min. Qty8 Shares
Issue Price₹ 1700.00
Live IPO
Antala Industries logo

Antala Industries

SME
Open  Close29th Oct 2026 - 5th Nov 2026
Issue Size22.98 Cr
Min. Qty2000 Shares
Issue Price₹ 62.00
Live IPO
Companies NameOpen - CloseIssue SizeMin. QtyIssue PriceApply
National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
17th Sep 2026 - 21st Sep 202622561.57 Cr8 Shares₹ 1700.00
Antala Industries logo

Antala Industries

SME
29th Oct 2026 - 5th Nov 202622.98 Cr2000 Shares₹ 62.00
See All Live IPOs
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Mahamaya Lifesciences

Mahamaya Lifesciences

Open Date

11 Nov 2025

Close Date

13 Nov 2025

listed

Min Investment

₹273600

Lot Size

2400 Shares

Issue Size

₹70.44 Cr

Price Range

₹108 - ₹114

Listing Date

Nov 18, 2025

IPO Doc

RHP PDF

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

Mahamaya Lifesciences IPO - Issue Objectives

The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant. ₹29.42 crore will be used to establish a new manufacturing plant. The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery. The company will utilise ₹18 crore for funding working capital requirement Part of the IPO proceeds will be used for general corporate purposes

Purchase of equipment

5.83%

Capital expenditure

45.77%

Construction of warehouse building

3.94%

Working capital

28%

General corporate purposes

16.5%

1

Purchase of equipment

The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant.

5.83%
2

Capital expenditure

₹29.42 crore will be used to establish a new manufacturing plant.

45.77%
3

Construction of warehouse building

The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery.

3.94%
4

Working capital

The company will utilise ₹18 crore for funding working capital requirement

28.00%
5

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes

16.50%

IPO Subscription Status

QIB
1.19x
NII
2.95x
Total
1.59x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Mahamaya Lifesciences

In Cr.

Key Performance Indicator30-Jun-25 (In Cr.)31-Mar-25 (In Cr.)31-Mar-24 (In Cr.)31-Mar-23 (In Cr.)
Revenue84.04267.17162.83137.40
EBITDA8.0424.6413.368.91
Expenses
Profit After Tax4.1012.945.223.75
Assets218.87188.35112.0777.88
Net Worth53.5049.4224.6619.44
Reserves35.7331.6623.4118.19
Borrowing57.7258.1154.6324.37

Mahamaya Lifesciences - Promoter(s)

Mahamaya Lifesciences

Krishnamurthy Ganesan Mrs

Lalitha Krishnamurthy Mr

Pre Issue Share Holding

N/A

Post Issue Share Holding

N/A

Registrar Contact Details

Kfin Technologies Ltd

Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1, Delhi, New Delhi, 110020

+91114656147404067162222
mahamaya.ipo@kfintech.com
https://www.mahamayalifesciences.com/

Mahamaya Lifesciences IPO - FAQs

Mahamaya Lifesciences IPO is a SME IPO. The issue is priced at ₹108-114 per equity share. The minimum order quantity is 2400 Shares. The IPO opens on 11 Nov, and closes on 13 Nov. Kfin Technologies Ltd is the registrar for the IPO. The shares are proposed to be listed on SME.









IPO Timeline

  • Pre Apply2025-11-10
  • Bidding Starts2025-11-11
  • Bidding Ends2025-11-13
  • Allotment Finalisation2025-11-14
  • Release of Funds2025-11-17
  • Demat Transfer2025-11-17
  • Listing2025-11-18